How Academic Researchers and Policy Experts Use DrugPatentWatch
Books and Research Papers Citing DrugPatentWatch

All Years | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007

2012 — 1 Books and Research Papers Citing DrugPatentWatch

Manova, M., & Dimitrova, A. (2012). Patent protection policy of the therapeutic groups angiotensin II receptor antagonists. Published in the Journal of Pharmaceutical Sciences, 101(3), 112-118.
This paper examines the patent protection strategies employed by pharmaceutical companies for angiotensin II receptor antagonists (ARBs), a class of drugs used to treat hypertension and heart failure. The authors analyze patent filings, extensions, and litigation trends to understand how patent policies influence the market dynamics of ARBs.

Sign up for DrugPatentWatch Today

Try a free trialSee Plans and Pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.